Table 2. Journals and impact factor scores by funding source (N=75).

Journal	Impact factor (2010)	Industry-sponsored studies		Non-profit/ government studies		No funding/ none disclosure
Circulation	14.8	1		0		0
J Am Coll Cardiol	14.3	1		0		0
Eur Heart J	10.0	3		0		2
Int J Cardiol	6.8	0		0		1
Am Heart J	5.0	1		1		0
Heart	4.7	0		1		0
Atherosclerosis	4.1	1		0		0
Am J Cardiol	3.7	3		1		1
Can J Cardiol	2.2	1		1		0
Rev Esp Cardiol	2.2	1		0		0
Arch Cardiovasc Dis	1.2	1		0		0
Acta Cardiol	0.6	1		0		0
Totalcardiovasc(n=22).		14 (67%)		3 (14%)		4 (19%)
N Engl J Med	53.5	1		0		0
JAMA	30.0	1		1		0
Ann Intern Med	16.7	0		2		0
BMJ	13.5	2		0		1
Arch Intern Med	10.6	0		1		1
CAMJ	9.0	1		0		0
J Intern Med	5.9	1		0		0
Med J Aust	2.7	1		1		0
Curr Med Res Opin	2.6	2		1		1
Totalmedicine(n=18)		9 (50%)		6 (33%)		3 (17%)
Pharmacoeconomics	3.4	6		0		0
Clin Ther	2.5	2		0		0
Ann Pharmacother	2.2	1		0		0
Clin Drug Investing	1.6	1		0		0
Totalpharmacol(n=10).		10 (100%)		0(0%)		0(0%)
Health Technol Assess	4.2	0		3		0
Value Health	2.3	3		0		0
Eur J Health Econ	1.8	2		0		0
Health Policy	1.4	0		0		1
Totalhealthpolicy(n=9)		5 (56%)		3 (33%)		1 (11%)
Diabetes care	7.1	1		0		0
Diabetologia	7.0	2		0		0
Totalendocrin(n=3).		3 (100%)		0(0%)		0(0%)
Rev Neurol	1.2	1		0		0
Other journals*	–	6		1		5
Totalothers(n=13)		7 (54%)		1 (8%)		5 (38%)

Note: PubMed/MEDLINE and Index Medicus abbreviations of journal titles are used.

* Journals not included in the 2010 Journal Citation Report.